DNDN DoNeDidN what it had to DoNeDoeN ...this time I gots the target spot on at $25 and "hopefully" they will hold this POS up into the close today. Is DNDN the most groslly overvalued $24 to $25 dallah stock on the planet? Well..can NE1 bring me one that is more grossly overvalued? Lemme know, sheeple. *-) 3J
Dendreon has released data from a subsequent trial that shows it met its primary end point for the trial, giving bulls their way and driving the stock to $30 and change - it is now around $28. The company is expecting an FDA decision - and approval - on or near May 1. Analysts peg Provenge sales at around one billion by 2018. The puts the current market cap is $3.25 billion.
DNDN is working to get everything that FDA will require to have their prostate drug approved. Before they ask for drug certification dndn will have the cash,factory and employees ready to start production..
DNDN DoNeDidN what it had to DoNeDoeN ...this time I gots the target spot on at $25 and "hopefully" they will hold this POS up into the close today. Is DNDN the most groslly overvalued $24 to $25 dallah stock on the planet? Well..can NE1 bring me one that is more grossly overvalued? Lemme know, sheeple. *-) 3J
Find Winning Stocks Quickly with Research Wizard, a powerful desktop software program. Start with easy-to-use pre-loaded strategies, then develop your own. Backtest against years of historical data to see how your approach works in any market. Start a Free Trial Today >>
Imagine seeing a small, private list of stocks with earnings that are growing like wildfire. And yet, their shares have somehow remained underpriced and undervalued. That's the strategy behind Growth Trader. Developed by Zacks' world-class stock screening expert, our tests against historical data show an average gain of +57.2% per year!Learn More>>
Rated #1 best-performing stock newsletter over the past 10 years by independent Hulbert Financial Digest. Zacks Elite gives you full access to the power of the Zacks Rank, plus the private, hand picked Focus List, Timely Buys and Growth & Income Portfolios. Start a Free Trial Today >>
Stock screening and chart patterns expert, Kevin Matras, combs through the best Zacks stock-picking strategies averaging +60% yearly gains to find stocks with charts showing they are ready to skyrocket. Chart Patterns Trader >>
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 5 | Comment
Comments: 0 | Comment
Comments: 0 | Comment